Listing of shares due to change in par value & reverse split of the Company’s shares
Peania, 20 July 2022 – Lavipharm S.A. (hereinafter the “Company”) informs the investment community that the Annual Shareholders Meeting held on 30 June 2022 decided, among other, to: (1) Increase share capital, through capitalisation of part of the share premium reserve above par, by EUR 81,037,877.00...

